Development of a point mutation assay for the detection of human cytomegalovirus UL97 mutations associated with ganciclovir resistance

Journal of Virological Methods

Volumn 68, Issue 2, 1997, Pages 225-234

  Bowen, E Frances ^a   Johnson, Margaret A ^a   Griffiths, Paul D ^a   Emery, Vincent C ^a  

^a ROYAL FREE HOSPITAL   (United Kingdom)

Author keywords

Cidofovir; Dynamics; Resistance; Therapy

Indexed keywords

ACICLOVIR; CIDOFOVIR; FOSCARNET; GANCICLOVIR; ZIDOVUDINE;

ARTICLE; CONTROLLED STUDY; CYTOMEGALOVIRUS INFECTION; DIAGNOSTIC VALUE; HUMAN; HUMAN CYTOMEGALOVIRUS; NONHUMAN; POINT MUTATION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; VIRUS DETECTION;

ACQUIRED IMMUNODEFICIENCY SYNDROME; CALIBRATION; CODON; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS RETINITIS; DRUG RESISTANCE; GANCICLOVIR; HUMANS; LINEAR MODELS; PHOSPHOTRANSFERASES (ALCOHOL GROUP ACCEPTOR); POINT MUTATION; PROSPECTIVE STUDIES; REPRODUCIBILITY OF RESULTS;

CYTOMEGALOVIRUS; HUMAN HERPESVIRUS 5;

EID: 0030800485     PISSN: 01660934     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0166-0934(97)00131-6     Document Type: Article

References (23)

1. Alain, S., Mazeron, M.C., Pepin, J.M., Bergmann, J.F., Narwa, R., Raskine, L., Sanson-Le Pors, M.J., 1995. Value of a new rapid non-radioactive sequencing method for analysis of the cytomegalovirus UL97 gene in ganciclovir-resistant strains. J. Virol. Methods 51 (2-3), 241-251.
2. Baldanti, F., Underwood, M.R., Stanat, S.C., Biron, K.K., Chou, S., Sarasini, A., Silini, E., Gerna, G., 1996. Single amino acid changes in the DNA polymerase confer foscarnet resistance and slow-growth phenotype, while mutations in the UL97-encoded phosphotransferase confer ganciclovir resistance in three double-resistant human cytomegalovirus strains recovered from patients with AIDS. J. Virol. 70 (3), 1390-1395.
3. Boivin, G., Chou, S., Quirk, M.R., Erice, A., Jordan, M.C., 1996. Detection of ganciclovir resistance mutations quantitation of cytomegalovirus (CMV) DNA in leukocytes of patients with fatal disseminated CMV disease. J. Infect. Dis. 173 (3), 523-528.
4. Bowen, E.F., Wilson, P., Cope, A., Sabin, C., Griffiths, P., Davey, C., Johnson, M., Emery, V., 1996. Cytomegalovirus retinitis in AIDS patients: influence of cytomegaloviral load on response to ganciclovir, time to recurrence and survival. AIDS 10 (13), 1515-1520.
5. Chee, M.S., Bankier, A.T., Beck, S., Bohni, R., Brown, C.M., Cerny, R., Horsnell, T., Hutchison, C.A. 3rd, Kouzarides, T., Martignetti, J.A., et al., 1990. Analysis of the protein-coding content of the sequence of human cytomegalovirus strain AD169. Curr. Top. Microbiol. Immunol. 154, 125-169.
6. Chou, S., Erice, A., Jordan, M.C., Vercellotti, G.M., Michels, K.R., Talarico, C.L., Stanat, S.C., Biron, K.K., 1995a. Analysis of the UL97 phosphotransferase coding sequence in clinical cytomegalovirus isolates and identification of mutations conferring ganciclovir resistance. J. Infect. Dis. 171 (3), 576-583.
7. Chou, S., Guentzel, S., Michels, K.R., Miner, R.C., Drew, W.L., 1995b. Frequency of UL97 phosphotransferase mutations related to ganciclovir resistance in clinical cytomegalovirus isolates. J. Infect. Dis. 172 (1), 239-242.
8. Collins, P., Darby, G., 1991. Laboratory studies of herpes simplex virus strains resistant to acyclovir. Rev. Med. Virol. 1, 19-28.
9. Crumpacker, C.S., 1996. Ganciclovir. New Engl. J. Med 335 (10), 721-729.
10. Darlington, J., Super, M., Patel, K., Grundy, J.E., Griffiths, P.D., Emery, V.C., 1991. Use of the polymerase chain reaction to analyse sequence variation within a major neutralizing epitope of glycoprotein B (gp58) in clinical isolates of human cytomegalovirus. J. Gen. Virol. 72 (8), 1985-1989.
11. Drew, W.L., Miner, R.C., Busch, D.F., Follansbee, S.E., Gullett, J., Mehalko, S.G., Gordon, S.M., Owen, W.F. Jr., Matthews, T.R., Buhles, W.C., et al., 1991. Prevalence of resistance in patients receiving ganciclovir for serious cytomegalovirus infection. J. Infect. Dis. 163 (4), 716-719.
12. Fox, J.C., Griffiths, P.D., Emery, V.C., 1992. Quantification of human cytomegalovirus DNA using the polymerase chain reaction. J. Gen. Virol. 73 (9), 2405-2408.
13. Fox, J.C., Kidd, I.M., Griffiths, P.D., Sweny, P., Emery, V.C., 1995. Longitudinal analysis of cytomegalovirus load in renal transplant recipients using a quantitative polymerase chain reaction: correlation with disease. J. Gen. Virol. 76 (2), 309-319.
14. Goudsmit, J., De Ronde, A., Ho, D.D., Perelson, A.S., 1996. Human immunodeficiency virus fitness in vivo: calculations based on a single zidovudine resistance mutation at codon 215 of reverse transcriptase. J. Virol. 70 (8), 5662-5664.
15. Hanson, M.N., Preheim, L.C., Chou, S., Talarico, C.L., Biron, K.K., Erice, A., 1995. Novel mutation in the UL97 gene of a clinical cytomegalovirus strain conferring resistance to ganciclovir. Antimicrob. Agents Chemother. 39 (5), 1204-1205.
16. Kaye, S., Loveday, C., Tedder, R.S., 1992. A microtitre format point mutation assay: application to the detection of drug resistance in human immunodeficiency virus type-1 infected patients treated with zidovudine. J. Med. Virol. 37 (4), 241-246.
17. Lalezari, J.P., Stagg, R.J., Kuppermann, B.D., Holland, G.N., Kramer, F., Ives, D.V., Youle, M., Robinson, M.R., Drew, W.L., Jaffe, H.S., 1997. Intravenous cidofovir for peripheral cytomegalovirus retinitis in patients with AIDS. A randomized, controlled trial. Ann. Intern. Med. 126 (4), 257-263.
18. Littler, E., Stuart, A.D., Chee, M.S., 1992. Human cytomegalovirus UL97 open reading frame encodes a protein that phosphorylates the antiviral nucleoside analogue ganciclovir. Nature 358 (6382), 160-162.
19. Lurain, N.S., Spafford, L.E., Thompson, K.D., 1994. Mutation in the UL97 open reading frame of human cytomegalovirus strains resistant to ganciclovir. J. Virol. 68 (7), 4427-4431.
20. Spector, S.A., McKinley, G.F., Lalezari, J.P., Samo, T., Andruczk, R., Follansbee, S., Sparti, P.D., Havlir, D.V., Simpson, G., et al., 1996. Oral ganciclovir for the prevention of cytomegalovirus disease in persons with AIDS. Roche Cooperative Oral Ganciclovir Study Group. New Engl. J. Med 334 (23), 1491-1497.
21. Studies of Ocular complications of AIDS Research Group (SOCA) in collaboration with the AIDS Clinical Trials Group, 1997. Parenteral cidofovir for cytomegalovirus retinitis in patients with AIDS: the HPMPC peripheral cytomegalovirus retinitis trial. A randomized, controlled trial. Ann. Intern. Med. 126 (4) 264-274.
22. Sullivan, V., Talarico, C.L., Stanat, S.C., Davis, M., Coen, D.M., Biron, K.K., 1992. A protein kinase homologue controls phosphorylation of ganciclovir in human cytomegalovirus-infected cells. Nature 358 (6382), 162-164.
23. Wolf, D.G., Smith, I.L., Lee, D.J., Freeman, W.R., Flores-Aguilar, M., Spector, S.A., 1995. Mutations in human cytomegalovirus UL97 gene confer clinical resistance to ganciclovir and can be detected directly in patient plasma. J. Clin. Invest. 95 (1), 257-263.